Ex parte ROOK et al. - Page 7




              Appeal No. 1998-0968                                                                                          
              Application No. 08/031,075                                                                                    
              when there are deficiencies in the record as to the necessary factual bases supporting” its                   
              determination, In re Warner, 379 F.2d 1011, 1017, 154 USPQ 173, 178 (CCPA 1967),                              
              cert. denied, 389 U.S. 1057 (1968), we find that the examiner has not established that                        
              Nahm anticipates the claimed invention.                                                                       
                     Turning to the aspect of the examiner’s rejection relating to the obviousness of the                   
              claimed invention, we find little more than a restatement of the anticipation aspect of the                   
              rejection (“[T]he information in [Nahm] specifically characterizing the anti-strep A                          
              antibodies . . . provided to a skilled worker in the art would have produced a monoclonal                     
              antibody having the same specificities and function as instantly claimed, with a reasonable                   
              expectation of success” Examiner’s Answer, pages 5 and 6).  We have already                                   
              determined that, on this record, Nahm’s antibody cannot be said to inherently possess all                     
              of the properties required by the present claims.  Nor, as appellants point out, does the                     
              examiner identify anything in the prior art which would suggest raising antibodies against                    
              Group A Streptococci and isolating those capable of binding both the terminal N-                              
              acetylglucosamine on the Group A Strep carbohydrate and mammalian cells.  Thus, we                            
              find this aspect of the rejection to be without merit.                                                        










                                                             7                                                              





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007